Synthesis, characterization and cytotoxic activity of binuclear copper(II)-complexes with some S-isoalkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II)-complex with S-isopropyl derivative of thiosalicylic acid

Wong, 1999, Current status of platinum-based antitumor drugs, Chem. Rev., 99, 2451, 10.1021/cr980420v Dilruba, 2016, Platinum-based drugs: past, present and future, Cancer Chemother. Pharmacol., 77, 1103, 10.1007/s00280-016-2976-z Boulikas, 2003, Cisplatin and platinum drugs at the molecular level. (Review), Oncol. Rep., 10, 1663 Gao, 2012, Novel palladium(II) complexes containing a sulfur ligand: structure and biological activity on HeLa cells, J. Biol. Inorg. Chem., 17, 263, 10.1007/s00775-011-0847-y Rubner, 2010, Synthesis and biological activities of transition metal complexes based on acetylsalicylic acid as neo-anticancer agents, J. Med. Chem., 53, 6889, 10.1021/jm101019j Katsaros, 2002, Rhodium and its compounds as potential agents in cancer treatment, Crit. Rev. Oncol. Hematol., 42, 297, 10.1016/S1040-8428(01)00222-0 Dai, 2012, Lewis acid-catalyzed, copper(II)-mediated synthesis of heteroaryl thioethers under base-free conditions, J. Org. Chem., 77, 4414, 10.1021/jo202624s Anjaneyulu, 1986, Preparation, characterization and antimicrobial activity studies on some ternary complexes of Cu(II) with acetylacetone and various salicylic acids, Synth. React. Inorg. Met. Chem., 16, 257, 10.1080/00945718608057530 Tisato, 2010, Copper in diseases and treatments, and copper-based anticancer strategies, Med. Res. Rev., 30, 708 Marzano, 2009, Copper complexes as anticancer agents, Anti Cancer Agents Med. Chem., 9, 185, 10.2174/187152009787313837 Iakovidis, 2011, Copper and its complexes in medicine: a biochemical approach, Mol. Biol. Int., 2011, 10.4061/2011/594529 Prudhomme, 2013 Santini, 2014, Advances in copper complexes as anticancer agents, Chem. Rev., 114, 815, 10.1021/cr400135x Moosun, 2015, Novel copper(II) thiodibenzoic acid coordination polymers by in situ extrusion of sulfur from 2,2-dithiodibenzoic acid and the unique oxidation of disulfide to sulfate, Zeitschrift Fur Anorg. Und Allg. Chemie., 641, 890, 10.1002/zaac.201500049 Wehr-Candler, 2016, Coordination chemistry of the thiosalicylate ligand, Coord. Chem. Rev., 313, 111, 10.1016/j.ccr.2016.01.011 Abu-Bakr, 1997, Complexation equilibria between copper(II) and thiosalicylic acid. Spectrophotometric determination of copper in non-ferrous alloys, Monatshefte Fur Chemie, 128, 563, 10.1007/BF00807586 Vivekananda, 2014, Supramolecular 3-/4-mercaptobenzoic acid complexes of palladium(II) and platinum(II) stabilized by hydrogen bonding, Eur. J. Inorg. Chem., 2153, 10.1002/ejic.201301562 Nomiya, 1995, Synthesis and characterization of polymeric, anionic thiosalicylato-Ag(I) complexes with antimicrobial activities, J. Inorg. Biochem., 58, 255, 10.1016/0162-0134(94)00059-J Nomiya, 1995, Synthesis and characterization of trisodium salt of bis(thiosalicylato)aurate(I): Na3[Au(TSA)2]·5H2O, J. Inorg. Biochem., 60, 289, 10.1016/0162-0134(95)00028-3 Gilbert, 2001, Copper(II) complexes of new unsymmetrical NSN thioether ligands, Inorg. Chim. Acta, 324, 123, 10.1016/S0020-1693(01)00564-3 Jin, 2018, Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN/AKT/NF-κB/survivin signaling pathway, Oncol. Lett., 15, 8454 Radić, 2012, Synthesis, characterization and antimicrobial activity of palladium(II) complexes with some alkyl derivates of thiosalicylic acids: crystal structure of the bis(S-benzyl-thiosalicylate)-palladium(II) complex, [Pd(S-bz-thiosal)2], Polyhedron, 31, 69, 10.1016/j.poly.2011.08.042 CrysAlisPRO Sheldrick, 2015, SHELXT - integrated space-group and crystal-structure determination, Acta Cryst. A, 71, 3, 10.1107/S2053273314026370 Sheldrick, 2015, Crystal structure refinement with SHELXL, Acta Cryst. C, 71, 3, 10.1107/S2053229614024218 Farrugia, 1999, WinGX suite for small-molecule single-crystal crystallography, J. Appl. Crystallogr., 32, 837, 10.1107/S0021889899006020 Brandenburg Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Milovanović, 2010, Ligand substitution reactions and cytotoxic properties of [Au(L)Cl2]+ and [AuCl2(DMSO)2]+ complexes (L=ethylenediamine and S-methyl-l-cysteine), J. Inorg. Biochem., 104, 944, 10.1016/j.jinorgbio.2010.04.014 Shounan, 1998, Apoptosis detection by annexin V binding: a novel method for the quantitation of cell-mediated cytotoxicity, J. Immunol. Methods, 217, 61, 10.1016/S0022-1759(98)00090-8 Nikolić, 2014, Synthesis, characterization and antimicrobial activity of copper(II)-complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II)-complex with S-methyl derivative of thiosalicylic acid, Polyhedron, 79, 80, 10.1016/j.poly.2014.04.053 Nakamoto, 1986 Silverstein, 1974 Nakamoto, 1963 Kizilcikli, 2007, Antimicrobial activity of a series of thiosemicarbazones and their Zn(II) and Pd(II) complexes, Folia Microbiol., 52, 15, 10.1007/BF02932132 Swaminathan, 1961, The synthesis and infrared absorption spectra of complexes of cobalt with pentadentate propylenediaminetetraacetic acid, J. Inorg. Nucl. Chem., 20, 159, 10.1016/0022-1902(61)80475-2 Godiksen, 2014, Coordination environment of copper sites in Cu-CHA zeolite investigated by electron paramagnetic resonance, J. Phys. Chem., 118, 23126 Thakurta, 2009, Ferromagnetic exchange coupling in a new bis(μ-chloro)-bridged copper(II) Schiff base complex: synthesis, structure, magnetic properties and catalytic oxidation of cycloalkanes, Polyhedron, 28, 695, 10.1016/j.poly.2008.12.016 Nikolić, 2016, Cytotoxicity of copper(II)-complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II)-complex with S-ethyl derivative of thiosalicylic acid, J. Mol. Struct., 1116, 264, 10.1016/j.molstruc.2016.03.058 Groom, 2016, The Cambridge structural database, Acta Cryst. B, 72, 171, 10.1107/S2052520616003954 Grem, 1993, A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma, Cancer, 72, 663, 10.1002/1097-0142(19930801)72:3<663::AID-CNCR2820720307>3.0.CO;2-V Planting, 1996, Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer, Br. J. Cancer, 72, 1265, 10.1038/bjc.1996.242 Smalley, 2007, Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels, Br. J. Cancer, 96, 445, 10.1038/sj.bjc.6603596